JP2008523018A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523018A5
JP2008523018A5 JP2007544844A JP2007544844A JP2008523018A5 JP 2008523018 A5 JP2008523018 A5 JP 2008523018A5 JP 2007544844 A JP2007544844 A JP 2007544844A JP 2007544844 A JP2007544844 A JP 2007544844A JP 2008523018 A5 JP2008523018 A5 JP 2008523018A5
Authority
JP
Japan
Prior art keywords
angiogenesis
diseases
general formula
angiogenic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007544844A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008523018A (ja
Filing date
Publication date
Priority claimed from DE102004061288A external-priority patent/DE102004061288A1/de
Application filed filed Critical
Publication of JP2008523018A publication Critical patent/JP2008523018A/ja
Publication of JP2008523018A5 publication Critical patent/JP2008523018A5/ja
Pending legal-status Critical Current

Links

JP2007544844A 2004-12-14 2005-12-12 脈管形成、高増殖性または神経変性疾患の治療のためのプロテインチロシンキナーゼの阻害剤としての3−アミノ−ピラゾロ[3,4b]ピリジン Pending JP2008523018A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004061288A DE102004061288A1 (de) 2004-12-14 2004-12-14 3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
US63669004P 2004-12-17 2004-12-17
PCT/EP2005/013417 WO2006063805A1 (de) 2004-12-14 2005-12-12 3-amino-pyrazolo[3,4b]pyridine als inhibitoren von proteintyrosinkinasen zur behandlung von angiogen, hyperproliferativen oder neurodegenerativen erkrankungen

Publications (2)

Publication Number Publication Date
JP2008523018A JP2008523018A (ja) 2008-07-03
JP2008523018A5 true JP2008523018A5 (enExample) 2013-05-23

Family

ID=36580240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544844A Pending JP2008523018A (ja) 2004-12-14 2005-12-12 脈管形成、高増殖性または神経変性疾患の治療のためのプロテインチロシンキナーゼの阻害剤としての3−アミノ−ピラゾロ[3,4b]ピリジン

Country Status (13)

Country Link
US (1) US7977325B2 (enExample)
EP (1) EP1846402B1 (enExample)
JP (1) JP2008523018A (enExample)
AR (1) AR051794A1 (enExample)
CA (1) CA2604463C (enExample)
DE (1) DE102004061288A1 (enExample)
DO (1) DOP2005000251A (enExample)
GT (1) GT200500363A (enExample)
PA (1) PA8656401A1 (enExample)
PE (1) PE20060737A1 (enExample)
TW (1) TW200634012A (enExample)
UY (1) UY29253A1 (enExample)
WO (1) WO2006063805A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
EP1980561B1 (en) * 2007-03-30 2013-10-09 Nerviano Medical Sciences S.R.L. Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
EA017648B1 (ru) 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
BRPI0816970A2 (pt) 2007-09-14 2015-03-24 Ortho Mcneil Janssen Pharm 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
US8173635B2 (en) * 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
CA2704436C (en) 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
WO2011019780A1 (en) 2009-08-11 2011-02-17 Bristol-Myers Squibb Company Azaindazoles as btk kinase modulators and use thereof
ES2460915T3 (es) 2009-12-21 2014-05-16 Novartis Ag Piridinas fusionadas con heteroarilo disustituido
JP2013534539A (ja) 2010-07-15 2013-09-05 ブリストル−マイヤーズ スクイブ カンパニー アザインダゾール化合物
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
FR2970967B1 (fr) * 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
FR2984325A1 (fr) * 2011-12-14 2013-06-21 Sanofi Sa Derives de pyrazolopyridine, leur procede de preparation et leur application en therapeutique
US10138235B2 (en) 2011-12-14 2018-11-27 Sanofi Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
EP2689778A1 (en) * 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindoles or diazaindoles for treating pain
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
WO2024211708A1 (en) * 2023-04-06 2024-10-10 Myrobalan Therapeutics, Inc. Tyk2 inhibitors for treatment of glaucoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2160780A1 (de) 1971-12-08 1973-06-14 Basf Ag Pyridino-pyrazole
DE2238400A1 (de) * 1972-08-04 1974-02-14 Hoechst Ag Basische azofarbstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE2355967A1 (de) 1973-11-09 1975-07-24 Hoechst Ag Polycyclische farbstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE2643753A1 (de) * 1976-09-29 1978-04-06 Thomae Gmbh Dr K Neue 1h-pyrazolo eckige klammer auf 3,4-b eckige klammer zu pyridine
DE3001498A1 (de) * 1980-01-17 1981-07-23 Agfa-Gevaert Ag, 5090 Leverkusen Fotografisches material mit einem stabilisierungsmittel, verfahren zu dessen herstellung, ein entwicklungsverfahren, neue pyrazole, ein verfahren zu deren herstellung sowie zwischenprodukte
US5478830A (en) * 1992-05-29 1995-12-26 The Du Pont Merck Pharmaceutical Company Fused-ring heterocycles for the treatment of atherosclerosis
US6046216A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
HK1053831A1 (zh) * 1999-09-17 2003-11-07 Basf Aktiengesellschaft 作为治疗药物的激酶抑制剂
HUP0700086A2 (en) * 2000-08-11 2007-05-29 Eisai Co Ltd 2-aminopyridine compounds, use thereof as drugs and pharmaceutical compositions containing them
JP4272338B2 (ja) * 2000-09-22 2009-06-03 バイエル アクチェンゲゼルシャフト ピリジン誘導体
FR2827603B1 (fr) 2001-07-18 2003-10-17 Oreal Composes derives de diaminopyrazole substitues par un radical heteroaromatique et leur utilisation en teinture d'oxydation des fibres keratiniques
ES2266618T3 (es) * 2001-08-23 2007-03-01 Bayer Cropscience S.A. Propargilaminas substituidas.

Similar Documents

Publication Publication Date Title
RU2416611C2 (ru) Бициклические амиды как ингибиторы киназы
DE502005006149D1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
WO2005123660A3 (en) Polycationic compounds and uses thereof
DE60331537D1 (de) Kombinationen zur behandlung von multiplem myelom
ATE453642T1 (de) Substituierte phenylaminopyrimidine
WO2009149486A3 (en) Compounds for treating beta-amyloidoses
ATE329596T1 (de) Phthalazinderivate zur behandlung von entzündlicher erkrankungen
EA201000341A1 (ru) 2-анилинопурин-8-оны в качестве ингибиторов ttk/mps1 для лечения пролиферативных нарушений
EE200200123A (et) Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning raviotstarbeline kasutamine
WO2007007919A3 (en) Heterocyclic janus kinase 3 inhibitors
EA200702387A1 (ru) Имидазохинолины в качестве ингибиторов липидкиназы
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
BRPI0415395A (pt) composto, métodos para inibir a atividade da proteìna quinase e para tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase, e, composição
EA200900388A1 (ru) Бензоксазолы и оксазолопиридины, применимые в качестве ингибиторов киназ janus
WO2009127642A3 (en) Use of lrrk2 inhibitors for neurodegenerative diseases
NO20080967L (no) Benzimidazoler nyttige som inhibitorer av proteinkinaser
WO2007120760A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
WO2010030936A3 (en) Novel autophagy regulators atg14l and rubicon
DE602005009162D1 (de) Alpha-aminoamidderivate zur behandlung des restless-leg-syndroms
ATE542814T1 (de) Pyrazinkinaseinhibitoren
ATE409028T1 (de) Arzneien zur behandlung von nervenerkrankungen
DE602004015425D1 (de) Pyridiniumsalze und deren verwendung
WO2008107211A3 (en) Novel p2y12 receptor antagonists
ATE494008T1 (de) Verwendung eines p38-kinasehemmers zur behandlung von psychiatrischen erkrankungen
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств